JNJ
Johnson & Johnson
- Research and development, FY2025
- $14.7B
- YoY, FY2025
- −14.9%
- 5-year CAGR
- +3.8%
- 10-year CAGR
- +5.0%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| FY2025 | $14.7B | −14.9% |
| FY2024 | $17.2B | +14.2% |
| FY2023 | $15.1B | +6.7% |
| FY2022 | $14.1B | −1.0% |
| FY2021 | $14.3B | +17.4% |
| FY2020 | $12.2B | +7.1% |
| FY2019 | $11.4B | +5.4% |
| FY2018 | $10.8B | +1.7% |
| FY2017 | $10.6B | +15.9% |
| FY2016 | $9.1B | +1.1% |
| FY2015 | $9.0B | +6.5% |
| FY2014 | $8.5B | +3.8% |
| FY2013 | $8.2B | +6.8% |
| FY2012 | $7.7B | +1.6% |
| FY2011 | $7.5B | +10.3% |
| FY2010 | $6.8B | −2.0% |
| FY2009 | $7.0B | −7.8% |
| FY2008 | $7.6B | −1.3% |
| FY2007 | $7.7B | — |